Results 111 to 120 of about 4,617,382 (195)

A Global Assessment of Coagulation Profile and a Novel Insight into Adamts-13 Implication in Neonatal Sepsis. [PDF]

Biology (Basel), 2023
Papadogeorgou P, Boutsikou T, Boutsikou M, Pergantou E, Mantzou A, Papassotiriou I, Iliodromiti Z, Sokou R, Bouza E, Politou M, Iacovidou N, Valsami S.   +11 more
europepmc   +1 more source

Targeting the von Willebrand Factor-ADAMTS-13 axis in sickle cell disease. [PDF]

J Thromb Haemost, 2023
Ellsworth P, Sparkenbaugh EM.
europepmc   +1 more source

A CASE OF THROMBOTIC THROMBOCYTOPENIC PURPURA RELATED TO MALIGNITY AND CHEMOTHERAPY

Hematology, Transfusion and Cell Therapy
Objective: Thrombotic thrombocytopenic purpura (TTP) is a life-threatening multisystem disease. TTP progresses with Microangiopathic hemolytic anemia (MAHA), fever, thrombocytopenia, neurological symptoms, and renal failure.
Ebru Kavak Yavuz, Songül Beskisiz Dönen, Etem Özkaya, Esra Pirinççi, Abdullah Karakuş, Orhan Ayyıldız   +5 more
doaj   +1 more source

Assay for ADAMTS-13 Activity with Flow Cytometric Readout. [PDF]

ACS Omega, 2022
Müller J, Hamedani NS, McRae HL, Rühl H, Oldenburg J, Pötzsch B.   +5 more
europepmc   +1 more source

The von Willebrand factor - ADAMTS-13 axis in malaria. [PDF]

Res Pract Thromb Haemost, 2022
O'Donnell AS, Fazavana J, O'Donnell JS.
europepmc   +1 more source

Proteolysis of ADAMTS-13 by thrombin does not influence the cleavage of, or binding to, VWF115

, 2011
(A) 5 n ADAMTS-13 or thrombin-cleaved ADAMTS-13 (ADAMTS-13/FIIa) was incubated at 37 °C with 5 μ VWF115, 150 m NaCl, 5 m CaCl, 20 m Tris (pH7.8).
C K N K CHION (48919), S ZANARDELLI (48920), J T B CRAWLEY (48922), J K LAM (48918), D A LANE (48921)   +4 more
core   +1 more source

Measuring ADAMTS-13 activity to diagnose thrombotic thrombocytopenic purpura: a novel, fast fiber-optic surface plasmon resonance immunoassay. [PDF]

Res Pract Thromb Haemost, 2023
Bonnez Q, Dekimpe C, Tellier E, Kaplanski G, Verhamme P, Tersteeg C, De Meyer SF, Lammertyn J, Joly B, Coppo P, Veyradier A, Vanhoorelbeke K.   +11 more
europepmc   +1 more source

The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency

, 2005
Summary. Background: Accurate estimates of the incidence of thrombotic thrombocytopenic purpura (TTP) are important to assess the resources required for current treatments as well as to anticipate the need to develop new treatments.
George, J. N., Vesely, S. K., Terrell, D. R., Williams, L. A., Lämmle, B, Hovinga, J. A. K.   +5 more
core   +1 more source

Anti-inflammatory protective effect of ADAMTS-13 in murine arthritis models. [PDF]

J Thromb Haemost, 2022
Fukui S, Gutch S, Fukui S, Chu L, Wagner DD.   +4 more
europepmc   +1 more source

Recombinant ADAMTS 13 in thrombotic thrombocytopenic pupura

Oncoscience, 2017
Scully, Marie, Hibbard, Christopher, Ewenstein, Bruce   +2 more
openaire   +2 more sources